Investigators analyzed OABSS and IPSS scores from Japanese patients with lower urinary tract symptoms for seasonal differences.

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Urinary Tract Infections (UTIs) are a common health concern, especially for women. Understanding the causes, symptoms, and ...

Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first ...

An elevated urinary sodium/potassium (Na/K) ratio is an independent risk factor for overactive bladder (OAB), investigators reported at the 2024 annual meeting of the International Continence Society ...

The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat a type of urinary tract ...

Most urinary tract infections (UTIs) are caused by the E. coli bacteria, which are treated with antibiotics. But some strains may be resistant to common antibiotic types. For the most part ...

Not much is known about how D-mannose works, but many experts believe it inhibits the ability of certain infectious bacteria to adhere to the cells of your urinary tract, making it easier for them ...

Urinary tract infections (UTIs) are infections in the urinary system, which consists of the urethra, bladder, kidneys, and ureters. UTIs typically occur when bacteria enter the bladder or urethra ...

Urinary continence can be temporary. Temporary incontinence could be caused by a urinary tract infection, pregnancy, constipation, and certain medications and beverages. What types of urinary ...